Medicated Skin Care in Italy
Euromonitor International's Medicated Skin Care in Italy market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 54 | Publication date: Mar 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Acne treatments; Antiparasitics/lice (head and body) treatments; Antipruritics; Child-specific medicated skin care; Emollients/therapeutic moisturisers; Haemorrhoid treatments; Hair loss treatments; Lip care treatments; Medicated shampoos; Nappy (diaper) rash treatments; Topical allergy remedies/antihistamines; Topical antifungals; Topical germicidals/antiseptics; Vaginal antifungals
Table of contents
MEDICATED SKIN CARE IN ITALY : MARKET INSIGHT
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 1 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 2 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 3 Herbal vs Standard Medicated Skin Care 2003-2008
Table 4 Acne Treatments by Format: % Value Breakdown 2004-2008
Table 5 Medicated Skin Care Company Shares by Value 2004-2008
Table 6 Medicated Skin Care Brand Shares by Value 2005-2008
Table 7 Acne Treatments Brand Shares by Value 2005-2008
Table 8 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 9 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 10 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
LOCAL COMPANY PROFILES - ITALY
A MENARINI INDUSTRIE FARMACEUTICHE RIUNITE SRL - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 1 A Menarini Industrie Farmaceutiche Riunite Srl: Key Facts
Summary 2 A Menarini Industrie Farmaceutiche Riunite Srl: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 3 A Menarini Industrie Farmaceutiche Riunite Srl: Competitive Position 2008
AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO ACRAF SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 4 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Key Facts
Summary 5 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 6 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 7 Aziende Chimiche Riunite Angelini Francesco ACRAF SpA: Competitive Position 2008
BAYER SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 8 Bayer SpA: Key Facts
Summary 9 Bayer SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 10 Bayer SpA: Competitive Position 2008
BRACCO SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 11 Bracco SpA: Key Facts
Summary 12 Bracco SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 13 Bracco SpA: Competitive Position 2008
CHIESI FARMACEUTICI SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 14 Chiesi Farmaceutici SpA: Key Facts
Summary 15 Chiesi Farmaceutici SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 16 Chiesi Farmaceutici SpA: Competitive Position 2008
PERFETTI VAN MELLE SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 17 Perfetti Van Melle SpA: Key Facts
Summary 18 Perfetti Van Melle SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 19 Perfetti Van Melle SpA: Competitive Position 2008
RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 20 Recordati Industria Chimica e Farmaceutica SpA: Key Facts
Summary 21 Recordati Industria Chimica e Farmaceutica SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 22 Recordati Industria Chimica e Farmaceutica SpA: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 23 Recordati Industria Chimica e Farmaceutica SpA: Competitive Position 2008
SANOFI-AVENTIS SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 24 Sanofi-Aventis SpA: Key Facts
Summary 25 Sanofi-Aventis SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 26 Sanofi-Aventis SpA: Competitive Position 2008
SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 27 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Key Facts
Summary 28 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 29 Sigma-Tau Industrie Farmaceutiche Riunite SpA: Competitive Position 2008
ZAMBON ITALIA SPA - OTC HEALTHCARE - ITALY
STRATEGIC DIRECTION
KEY FACTS
Summary 30 Zambon Italia SpA: Key Facts
Summary 31 Zambon Italia SpA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 32 Zambon Italia SpA: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 33 Zambon Italia SpA: Competitive Position 2008
OTC HEALTHCARE IN ITALY
EXECUTIVE SUMMARY
A positive result driven by price liberalisation
The weak effects of deregulation
A fragmented market led by Bayer
Chemists/pharmacies remain the undisputed leaders
Vitamins and dietary supplements will be growth driver
KEY TRENDS AND DEVELOPMENTS
A very old country
What price? The effects of price liberalisation
The results of the new Bersani law
Are parapharmacies/drugstores true competitors?
The need for a healthier lifestyle
Pharmaclick - a new distributor?
MARKET DATA
Table 11 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 12 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 13 OTC Healthcare Company Shares by Value 2004-2008
Table 14 OTC Healthcare Brand Shares by Value 2005-2008
Table 15 Penetration of Private Label by Sector 2003-2008
Table 16 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 17 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 18 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 19 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
De-listing or De-reimbursement
Advertising
Packaging and Waste
Labelling
Distribution
Vitamins and Dietary Supplements Registration and Classification
EU Legislation
Self-medication and Preventive Medicine
Generics
Switches
Summary 34 OTC Healthcare Switches 2005-2007
DEFINITIONS
Sources
Summary 35 Research Sources